12 Results for "

CCL25

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "CCL25" in MCE Product Catalog:

  • Recombinant Proteins Recommended:
5
5 Cited Publications
製品番号: HY-15724
CAS 番号: 698394-73-9
純度:  98.26%
別名: GSK-1605786; CCX282-B; Traficet-EN
Vercirnon (GSK1605786A) is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon inhibits CCR9-mediated Ca 2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, respectively. Vercirnon is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC50s>10 μM for all). Vercirnon is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, respectively .
loading...
    loading...
5
5 Cited Publications
製品番号: HY-15724A
CAS 番号: 886214-18-2
純度:  99.13%
別名: GSK-1605786 sodium; CCX282-B sodium; Traficet-EN sodium
Target:  

CCR

Vercirnon (GSK1605786A) sodium is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon sodium inhibits CCR9-mediated Ca 2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, respectively. Vercirnon sodium is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC50s>10 μM for all). Vercirnon sodium is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, respectively .
loading...
    loading...
製品番号: HY-123763
CAS 番号: 628300-71-0
純度:  98.64%
Target:  

CCR

研究分野:  

Inflammation/Immunology

MLN3126 is an orally active and potent CCR9 antagonist. MLN3126 inhibits CCL25-induced calcium mobilization and chemotaxis of mouse primary thymocytes, wiht an IC50 value of 6.3 nM for calcium influx .
loading...
    loading...
製品番号: HY-RS02095
研究分野:  

Others

CCL25 Human Pre-designed siRNA Set A contains three designed siRNAs for CCL25 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
製品番号: HY-RS17131
研究分野:  

Others

Ccl25 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ccl25 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
製品番号: HY-P991168
CAS 番号: 2988741-17-7
Velaprumig is a monoclonal antibody targeting human CD99, CCL25, and anti-human Aβ (Aβ-47F). Velaprumig regulates immune cell migration and reduces β-amyloid-related pathological processes, exerting immunomodulatory and potential anti - Alzheimer's disease activities .
loading...
    loading...
製品番号: HY-174757
Target:  

mRNA

研究分野:  

Inflammation/Immunology

Human CCL25 mRNA encodes the human C-C motif chemokine ligand 25 (CCL25) protein, a cytokine that displays chemotactic activity for dendritic cells, thymocytes, and activated macrophages but is inactive on peripheral blood lymphocytes and neutrophils.
loading...
    loading...
製品番号: HY-RS23576
研究分野:  

Others

Ccl25 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ccl25 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
製品番号: HY-15724AR
CAS 番号: 886214-18-2
別名: GSK-1605786 sodium (Standard); CCX282-B sodium (Standard); Traficet-EN sodium (Standard)
Vercirnon (sodium) (Standard) is the analytical standard of Vercirnon (sodium). This product is intended for research and analytical applications. Vercirnon (GSK1605786A) sodium is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon sodium inhibits CCR9-mediated Ca2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, respectively. Vercirnon sodium is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC50s>10 μM for all). Vercirnon sodium is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, respectively .
loading...
    loading...
製品番号: HY-15724R
CAS 番号: 698394-73-9
別名: GSK-1605786 (Standard); CCX282-B (Standard); Traficet-EN (Standard)
Vercirnon (Standard) is the analytical standard of Vercirnon. This product is intended for research and analytical applications. Vercirnon (GSK1605786A) is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon inhibits CCR9-mediated Ca2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, respectively. Vercirnon is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC50s>10 μM for all). Vercirnon is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, respectively .
loading...
    loading...
製品番号: HY-P71893
純度:  ≥ 95%, as determined by reducing SDS-PAGE.
別名: CCL25; Scya25; Teck; C-C motif chemokine 25; Chemokine TECK; Small-inducible cytokine A25; Thymus-expressed chemokine
Species:  
Source:  
loading...
    loading...
製品番号: HY-P7294
純度:  ≥ 95%, as determined by reducing SDS-PAGE.
別名: rHuTECK/CCL25; C-C motif chemokine 25; SCYA25
Species:  
Source:  
loading...
    loading...
  • 1